IL 17 Inhibitors in Psoriatic Disease: Are they here to stay?

With many options of biologics now available for moderate to severe psoriasis, dermatologists are spoilt for choice. Understanding where each biologic treatment works best becomes an important goal to ensure the best option is picked for the right patient.

This masterclass focuses on reviewing the anti-IL 17 class of biologics and seeing where they stand within the currently available options. Prof Thaci from Germany will shares his experience and guidance on this topic.

Scroll to Top